Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia

被引:34
作者
Segal, BH
Walsh, TJ
Liu, JM
Wilson, JD
Kwon-Chung, KJ
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Mol Biol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[3] NCI, Immunocompromised Host Sect, Pediat Branch, NIH, Bethesda, MD 20892 USA
[4] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
[5] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JCM.36.6.1772-1776.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report the first case of invasive disease caused by Fusarium chlamydosporum. The patient had aplastic anemia with prolonged neutropenia and was treated with immunosuppressive therapy. While she was receiving empirical amphotericin B, a dark crusted lesion developed on her nasal turbinate. Histologic analysis revealed invasive hyaline hyphae and some darkly pigmented structures that resembled conidia of dematiaceous molds. Only after the mold was grown in culture were characteristic colonial morphology, phialides, conidia, and chlamydospores evident, thus permitting the identification of F. chlamydosporum. This case illustrates the ever-increasing spectrum of pathogenic Fusarium spp. in immunocompromised patients and emphasizes the potential pitfalls in histologic diagnosis, which may have important treatment implications.
引用
收藏
页码:1772 / 1776
页数:5
相关论文
共 32 条
[1]   THE EMERGING ROLE OF FUSARIUM INFECTIONS IN PATIENTS WITH CANCER [J].
ANAISSIE, E ;
KANTARJIAN, H ;
RO, J ;
HOPFER, R ;
ROLSTON, K ;
FAINSTEIN, V ;
BODEY, G .
MEDICINE, 1988, 67 (02) :77-83
[2]  
ANAISSIE E, 1989, REV INFECT DIS, V11, P369
[3]  
ANAISSIE E, 1986, CANCER-AM CANCER SOC, V57, P2141, DOI 10.1002/1097-0142(19860601)57:11&lt
[4]  
2141::AID-CNCR2820571110&gt
[5]  
3.0.CO
[6]  
2-N
[7]   EMERGING FUNGAL PATHOGENS [J].
ANAISSIE, EJ ;
BODEY, GP ;
RINALDI, MG .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (04) :323-330
[8]   Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management [J].
Boutati, EI ;
Anaissie, EJ .
BLOOD, 1997, 90 (03) :999-1008
[9]   COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI [J].
ESPINELINGROFF, A ;
DAWSON, K ;
PFALLER, M ;
ANAISSIE, E ;
BRESLIN, B ;
DIXON, D ;
FOTHERGILL, A ;
PAETZNICK, V ;
PETER, J ;
RINALDI, M ;
WALSH, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :314-319
[10]  
Fukuzawa M, 1995, VIRCHOWS ARCH, V427, P407, DOI 10.1007/BF00199390